Lombard Medical, Inc. (EVARF)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: May 29, 2025
Lombard Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | 2007 - 2011 |
|---|---|---|---|---|---|---|
Period Ending | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 | 2007 - 2011 |
| Revenue | 12.17 | 15.11 | 13.28 | 6.96 | 6.18 | Upgrade
|
| Revenue Growth (YoY) | -19.48% | 13.84% | 90.76% | 12.71% | -3.89% | Upgrade
|
| Cost of Revenue | 11.03 | 8.3 | 7.54 | 4.32 | 3.95 | Upgrade
|
| Gross Profit | 1.14 | 6.82 | 5.74 | 2.65 | 2.22 | Upgrade
|
| Selling, General & Admin | 18.99 | 34.63 | 31.16 | 15.72 | 8.01 | Upgrade
|
| Research & Development | 7.67 | 11.28 | 9.21 | 6.96 | 7.3 | Upgrade
|
| Operating Expenses | 26.66 | 45.91 | 40.38 | 22.68 | 15.31 | Upgrade
|
| Operating Income | -25.52 | -39.09 | -34.64 | -20.03 | -13.09 | Upgrade
|
| Interest Expense | -2.35 | -1.19 | -0.08 | -0.45 | -0.67 | Upgrade
|
| Interest & Investment Income | 0.09 | 0.13 | 0.25 | 0.16 | 0.04 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.04 | - | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 1.41 | 0.33 | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -26.33 | -39.82 | -34.48 | -20.32 | -13.72 | Upgrade
|
| Merger & Restructuring Charges | - | -0.2 | - | - | - | Upgrade
|
| Impairment of Goodwill | -0.86 | - | - | - | - | Upgrade
|
| Asset Writedown | -2.5 | - | - | - | - | Upgrade
|
| Other Unusual Items | -2.83 | - | -1.5 | - | - | Upgrade
|
| Pretax Income | -32.52 | -40.02 | -35.98 | -20.32 | -13.72 | Upgrade
|
| Income Tax Expense | -1.48 | -2.22 | -1.23 | -1.12 | -0.56 | Upgrade
|
| Earnings From Continuing Operations | -31.04 | -37.8 | -34.75 | -19.2 | -13.16 | Upgrade
|
| Net Income | -31.04 | -37.8 | -34.75 | -19.2 | -13.16 | Upgrade
|
| Net Income to Common | -31.04 | -37.8 | -34.75 | -19.2 | -13.16 | Upgrade
|
| Shares Outstanding (Basic) | 20 | 18 | 15 | 9 | 5 | Upgrade
|
| Shares Outstanding (Diluted) | 20 | 18 | 15 | 9 | 5 | Upgrade
|
| Shares Change (YoY) | 13.60% | 21.99% | 62.24% | 77.98% | 23.55% | Upgrade
|
| EPS (Basic) | -1.54 | -2.13 | -2.39 | -2.14 | -2.61 | Upgrade
|
| EPS (Diluted) | -1.54 | -2.13 | -2.39 | -2.14 | -2.61 | Upgrade
|
| Free Cash Flow | -25.46 | -35.04 | -35.85 | -19.6 | -12.13 | Upgrade
|
| Free Cash Flow Per Share | -1.26 | -1.97 | -2.46 | -2.18 | -2.41 | Upgrade
|
| Gross Margin | 9.38% | 45.11% | 43.20% | 38.00% | 36.00% | Upgrade
|
| Operating Margin | -209.72% | -258.65% | -260.90% | -287.84% | -211.92% | Upgrade
|
| Profit Margin | -255.03% | -250.13% | -261.75% | -275.92% | -213.15% | Upgrade
|
| Free Cash Flow Margin | -209.22% | -231.81% | -270.05% | -281.59% | -196.42% | Upgrade
|
| EBITDA | -24.22 | -37.66 | -33.47 | -19.49 | -12.78 | Upgrade
|
| EBITDA Margin | -199.03% | -249.17% | -252.08% | -280.00% | -206.90% | Upgrade
|
| D&A For EBITDA | 1.3 | 1.43 | 1.17 | 0.55 | 0.31 | Upgrade
|
| EBIT | -25.52 | -39.09 | -34.64 | -20.03 | -13.09 | Upgrade
|
| EBIT Margin | -209.72% | -258.65% | -260.90% | -287.84% | -211.92% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.